EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Dual Role of Chemerin in Lung Diseases

Philomène Lavis, Benjamin Bondue, Alessandra Kupper Cardozo

Cells · 16.01.2024 · 13 (2) · 171

DOI: 10.3390/cells13020171 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 16.01.2024. Verfasst von Philomène Lavis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Brussels University Hospital, Université Libre de Bruxelles, 1070 Brussels, Belgium. Hauptthemen laut MEDLINE: Chemokines, Chemotactic Factors, Lung Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Belgian National Fund for Scientific Research, Fonds Erasme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemerin is an atypical chemokine first described as a chemoattractant agent for monocytes, natural killer cells, plasmacytoid and myeloid dendritic cells, through interaction with its main receptor, the G protein-coupled receptor chemokine-like receptor 1 (CMKLR1). Chemerin has been studied in various lung disease models, showing both pro- and anti-inflammatory properties. Given the incidence and burden of inflammatory lung diseases from diverse origins (infectious, autoimmune, age-related, etc.), chemerin has emerged as an interesting therapeutical target due to its immunomodulatory role. However, as highlighted by this review, further research efforts to elucidate the mechanisms governing chemerin’s dual pro- and anti-inflammatory characteristics are urgently needed. Moreover, although a growing body of evidence suggests chemerin as a potential biomarker for the diagnosis and/or prognosis of inflammatory lung diseases, this review underscores the necessity for standardizing both sampling types and measurement techniques before drawing definitive conclusions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChemokinesChemotactic FactorsLung DiseasesHumansAnti-Inflammatory AgentsDendritic Cells

Stichwörter der Autor:innen

CMKLR1RARRES2chemerininflammationlung

Substanzen

Anti-Inflammatory AgentsChemokinesChemotactic FactorsRARRES2 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Brussels University Hospital, Université Libre de Bruxelles, 1070 Brussels, Belgium.
  • Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (I.R.I.B.H.M.), Université Libre de Bruxelles, 1070 Brussels, Belgium.
  • Department of Pneumology, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, 1070 Brussels, Belgium.
  • Inflammation and Cell Death Signalling Group, Signal Transduction and Metabolism Laboratory, Université Libre de Bruxelles, 1070 Brussels, Belgium.

Förderung

  • Belgian National Fund for Scientific Research
  • Fonds Erasme

Zitieren

APA

Lavis, P., Bondue, B., & Cardozo, A. K. (2024). The Dual Role of Chemerin in Lung Diseases. Cells, 13(2), 171. https://doi.org/10.3390/cells13020171

Vancouver

Lavis P, Bondue B, Cardozo AK. The Dual Role of Chemerin in Lung Diseases. Cells. 2024;13(2):171. doi:10.3390/cells13020171

BibTeX
@article{Lavis2024,
  author = {Lavis, Philomène and Bondue, Benjamin and Cardozo, Alessandra Kupper},
  title = {The Dual Role of Chemerin in Lung Diseases},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {2},
  pages = {171},
  doi = {10.3390/cells13020171}
}
Kostenlos starten →